Skip to main content
. 2020 Oct 9;15(10):e0240172. doi: 10.1371/journal.pone.0240172

Table 3. Proportions of newborns with congenital CMV infection with and without hearing loss by age 18 years of age, and type of maternal CMV infection.

Symptomatic Asymptomatic Control Row Totals
Hearing Loss (HL) HL/n Proportion (95% CI) p HL/n Proportion (95% CI) p HL/n Proportion (95% CI) p HL/n Proportion (95% CI) p
Primary 9/12 75.0% .009 14/51 27.5% .157 1/10 10.0% .462 24/73 32.9% < .001
(0.0–28.6) (22.1–43.7)
(50.5–99.5) (15.2–39.7)
non-Primary 0/4 0 2/18 11.1% 0/5 0 2/27 7.4%
(0.0–25.6) (0.0–17.3)
No Infection - - - - 1/10 10.0% 1/10 10.0%
(0.0–28.6)
(0.0–28.6)
Unknown 48/61 78.7% 6/40 15% 1/26 3.8% 55/127 43.3%
(68.4–89.0) (3.9–26.1) (0.0–11.2) (34.7–51.9)
Column Totals 57/77 74.0% 22/109 20.2% 3/51 5.9% 82/237 34.6%
(0.0–12.3) (28.5–40.7)
(64.2–83.8) (12.6–27.7)
Trimester of Infection (Primary Infections Only):
1st 2/3 66.7% 3/9 33.0% 0/4 0.0% 5/16 31.3%
(13.3–1.00) (2.5–64.1) (8.5–54.0)
1st or 2nd 0/0 0.0% 1 / 2 50% 0/0 0% 1/2 50.0%
(0.0–1.0)
(0.0–1.0)
2nd 1/1 100% 3/11 27.3% 0/0 0% 4/12 33.3%
(1.0–1.0) (0.1–53.6) (6.7–60.0)
2nd or 3rd 2/2 100% 2/6 33.3% 0/0 0% 4/8 50.0%
(15.4–84.6)
(1.0–1.0) (0.0–71.1)
3rd 3/3 100% 5/20 25.0% 1/5 20.0% 9/28 32.1%
(6.0–44.0) (0.0–55.1) (14.8–49.4)
(1.0–1.0)
Unknown 1/3 33.3% 0/3 0.0% 0/1 0.0% 1/7 14.3%
(0.0–86.7) (0.0–40.2)
Totals 9/12 75% 14/51 27.5% 1/10 10.0% 24/73 32.9%
(15.2–39.7) (0.0–28.6) (22.1–43.7)
(50.5–99.5)
Pregnancy Half When Infected (Primary Infections Only)
First Half of Pregnancy 3/4 75% .444 5/15 33.3% .669 0/4 0.0% 1.000 8/23 34.8% .858
(32.6–1.0) (9.5–57.2) (15.3–54.2)
Second Half of Pregnancy 5/5 100% 9/33 27.3% 1/5 20.0% 14/43 32.6%
(1.0–1.0) (12.1–42.5) (0.0–55.1) (18.6–46.6)
Unknown 1/3 33.3% 0/3 0% 0/1 0% 1/7 14.3%
(0.0–86.7) (0.0–40.2)
Totals 8/12 75.0% 14/51 27.5% 1/10 10.0% 23/73 31.5%
(40.0–93.3) (20.9–42.2)
(15.2–39.7) (0.0–28.6)